Modificazioni epigenetiche nell'obesità: pathway molecolari, nutrienti bioattivi e target terapeutici
Year: 2026
Type: dissertation
Abstract: Obesity is a clinical condition characterized by complex management that spans many aspects of a patient's life. As with all pathologies, understanding its etiopathogenesis is fundamental for developing correct and functional treatments, both pharmacological and non-pharmacological. Obesity has a consistent genetic component, and its identification and understanding are important for both diagnostic and therapeutic purposes. Three types of genetic obesity have been identified to date: monogenic obesity, polygenic obesity (the most widespread form), and syndromic obesity. These forms share the common feature of weight gain, at times uncontrolled,and difficulty in adhering to an adequate dietary regimen. Although there are similarities between the various genetic forms, in the case of polygenic obesity, there appears to be greater responsiveness to therapeutic treatment and lifestyle modifications, such as increased daily physical activity and adherence to specific dietary protocols.Epigenetics correlates with obesity as it acts as the interface between genetic heritage and environmental exposure, explaining how these factors can mutually influence each other and sometimes encourage the onset of the disease. Obesity is not determined exclusively by excessive caloric intake and physical inactivity; instead, there may be other factors, such as epigenetic processes, that transcend individual will and are prodromal to the onset of the disease. These processes can induce gene silencing or determine an increase in the expression of genes related to metabolic control and the storage of fatty acids as triglycerides. Epigenetic modifications can persist in germ cells and be transmitted to offspring; for this reason, the metabolic state of parents at the time of conception can influence the development of the fetus, starting from early childhood. It is important to emphasize that adipose tissue, especially abdominal fat, is metabolically active—it behaves as a true endocrine organ which increases the body's chronic low-grade inflammatory state following the secretion of pro-inflammatory cytokines.Epigenetic processes are reversible, unlike genetic mutations which are permanent; therefore, it is possible to implement both pharmacological and nutritional interventions to reverse the weight gain trend. To date, adherence to certain dietary regimens, such as the Mediterranean diet and the SEAD diet, represents the first attempt at a nutritional intervention aimed at weight loss, generally accompanied by a caloric deficit. Preference is given to the consumption of fresh, unprocessed foods consisting of complex carbohydrates, fibers, proteins, and fats, preferably from the omega-3 series. Regarding fats used for seasoning, extra virgin olive oil is widely recommended as it is rich in functional bioactive compounds essential for the body's health. Both the Mediterranean and SEAD diets are characterized by the consumption of foods of nutraceutical interest, capable of providing health benefits. These foods, or parts of them, exert a protective action on the body and constitute a true non-pharmacological treatment for certain diseases (for example, fermented red rice has a "statin-like" action, meaning it acts similarly to a cholesterol-lowering drug). In the specific context of obesity, functional bioactive compounds can act as adjuvants to a balanced diet and an active lifestyle; from an epigenetic point of view, they act by modulating the expression of genes related to energy metabolism ($SIRT-1$), the generation of chronic inflammation (NFkB), and fat storage and lipid metabolism (PPAR-\gamma), through processes of DNA methylation, histone acetylation, or by increasing or decreasing the expression of certain microRNAs.Regarding the treatment of the disease, various classes of drugs and different dietary protocols are currently available for implementation. Firstly, adherence to a more active lifestyle is of fundamental importance, based on regular physical activity which, as recommended by the WHO, should be at least 150 minutes per week at moderate intensity or 75 minutes at high intensity, or equivalent combinations of the two, in sessions of at least 10 minutes to obtain cardio-respiratory benefits. Physical exercise is a very powerful epigenetic modulator capable of promoting the browning of white adipose tissue, mitochondrial biogenesis, and reducing systemic low-grade inflammation. Regardless of the therapeutic plan and dietary intervention, with few exceptions, the regular daily practice of motor activity is fundamental and necessary to achieve weight reduction and to act effectively on lifestyle changes, which are essential for making the results durable over time.To date, drugs for body weight management are widely marketed, subject to medical prescription, as they—confirmed by clinical trials and scientific studies—are capable of achieving significant weight loss, even in cases of very severe obesity (BMI > 40). The current Gold Standard for the pharmacological treatment of obesity is represented by GLP-1 and GIP agonist drugs, of which tirzepatide is the main and most widespread representative. Both this drug and other analogs, such as semaglutide, present a combined and cross-sectional action that allows for rapid and consistent weight loss (up to 22% of body weight). These results were considered surprising and promising, especially since these drugs were initially formulated for the treatment of type 2 diabetes. Only later, given the results obtained, were they also approved for obesity. Generally, drugs used for the treatment of said disease also act at an epigenetic level, serving as powerful modulators of gene expression and restoring the cell's ability to correctly process introduced nutrients. Regarding nutritional intervention, the Gold Standard is represented by the ketogenic diet, which is also considered as powerful and promising as pharmacological treatment. The production of ketone bodies inhibits the feeling of hunger and allows for rapid weight loss, acting simultaneously from an epigenetic point of view by restoring correct metabolic patterns.It is clear that there is currently significant attention toward this pathology, long considered a mere result of caloric excess; however, the development of specific dietary protocols and the formulation of weight-loss drugs are accompanied by necessary reflections and considerations. The use of drugs and nutritional protocols is fundamental for acting immediately on the signs and symptoms of the disease; nonetheless, close monitoring of the patient receiving such administration is necessary, as it could exacerbate latent dysfunctional eating behaviors or cause them to appear ex novo. Patients suffering from eating disorders must be carefully monitored and evaluated, because by removing the hedonic pleasure of food—the objective of pharmacological treatment—one could trigger eating disorders that are difficult to remit. In recent years, especially in America, the marketing of the semaglutide-based drug, Ozempic, has become uncontrollable, leading to a real "race for the drug" to achieve weight loss. This made the doses intended for diabetic subjects unavailable for a certain period and generated significant controversy related specifically to this easy availability.In conclusion, it is evident how obesity, due to its multifactorial etiology, is complex to manage, especially if dysfunctional eating habits and behaviors that are difficult to eradicate are present alongside genetic predisposition. Pharmacological treatment, as well as adherence to specific dietary regimens and protocols, is functional, especially in the initial stages, for encouraging weight reduction; however, it is necessary to have principles of nutritional education at the core, which should be transmitted from early childhood. The relationship with food and body image are frequently correlated with issues based on the difficult acceptance of one's body and the complicated processing of the hunger signal, which appears physiological but constitutes the foundation of the etiopathogenesis of eating disorders. In this sense, the advancement of scientific studies and experimentation is crucial for formulating increasingly functional drugs with minimal side effects; it is also important to act upstream, investigating the triggering causes and, where possible, implementing a multidisciplinary intervention aimed at the permanent psychophysical well-being of the patient.
Author: VALENZA, MILA
Institution: University of Pisa
Language: Italian
Subfield: Molecular Biology
Domain: Life Sciences
Keywords: obesity, epigenetics, polygenic obesity, monogenic obesity, syndromic obesity, gene silencing, epigenetic inheritance, adipose tissue endocrine function, low-grade inflammation, Mediterranean diet, nutraceuticals, omega-3 fatty acids, extra virgin olive oil, bioactive compounds, weight loss, lifestyle modification, therapeutic target, caloric deficit
Open Access status: green
OpenAlex ID: W7142575543
